PATENT CLAIM ANALYSIS

Application Number: 15775312
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "234500"]

Abstract:
The present invention relates to a 7-azaindolin-2-one derivative or a pharmaceutically acceptable salt thereof, and the 7-azaindolin-2-one derivative or the pharmaceutically acceptable salt thereof can be favorably used as a medicinal material for inhibiting cancer growth and cancer metastasis.

Claim (Index 7):
A method for preparing a compound of the following Formula 1, comprising reacting a compound of the following Formula 2 with a compound of the following Formula 3: wherein, R 1 , R 4  and R 5  each independently represent any one selected from the group consisting of hydrogen; halogen; and C 1 -C 4  alkyl; R 2  and R 3  each independently represent C 1 -C 4  alkyl; R 6  represents any one selected from the group consisting of hydrogen; C 1 -C 12  alkyl; C 2 -C 12  alkenyl; C 6 -C 12  aryl; and C 3 -C 12  heteroaryl containing 1 to 3 heteroatoms; wherein the C 1 -C 12  alkyl or the C 2 -C 12  alkenyl is unsubstituted or substituted with C 6 -C 12  aryl; the C 6 -C 12  aryl is unsubstituted or substituted with one or more substituents selected from the group consisting of halogen; \u2014NO 2 ; C 1 -C 4  alkyl; \u2014OR 11 ; and \u2014NR 20 R 21 ; the C 3 -C 12  heteroaryl is unsubstituted or substituted with one or more substituents selected from the group consisting of C 1 -C 4  alkyl; \u2014C(O)R 14 ; \u2014C(O)OR 15 ; and \u2014C(O)NR 22 R 23 ; R 11 , R 14  and R 15  each independently represent any one selected from the group consisting of hydrogen; and C 1 -C 4  alkyl; R 20  to R 23  each independently represent any one selected from the group consisting of hydrogen; and C 1 -C 6  alkyl, or R 22  and R 23  taken together form C 3 -C 8  heteroaryl containing 1 to 3 heteroatoms; wherein the C 1 -C 4  alkyl and the C 3 -C 8  heteroaryl of R 11 , R 14 , R 15 , and R 20  to R 23  are each independently unsubstituted or substituted with one or more substituents selected from the group consisting of C 1 -C 4  alkyl; and \u2014NR 24 R 25 ; R 24  and R 25  each independently represent any one selected from the group consisting of hydrogen; and C 1 -C 4  alkyl, or R 24  and R 25  taken together form C 3 -C 8  heteroaryl containing 1 to 3 heteroatoms.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.41379
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13196391', '12451466', '12223180', '13945924', '13106076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7504863871045485
- 35 USC 102 Novelty (BERT): 0.5267368697902614
- Combined Prediction Score: 0.7281114353731197
- Mean Citation Score: 311.092622
- Max Citation Score: 313.8167
- Similarity Product: 208.43142443920377

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test